Item Type | Name |
Concept
|
Disease Models, Animal
|
Concept
|
Brain Diseases
|
Concept
|
Neurodegenerative Diseases
|
Concept
|
Chronic Disease
|
Concept
|
Disease Susceptibility
|
Concept
|
Refsum Disease
|
Concept
|
Demyelinating Diseases
|
Concept
|
Alzheimer Disease
|
Concept
|
Disease Progression
|
Concept
|
Acute Disease
|
Concept
|
Tay-Sachs Disease
|
Concept
|
Lewy Body Disease
|
Concept
|
Lysosomal Storage Diseases
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Nervous System Diseases
|
Concept
|
Lung Diseases
|
Concept
|
Parkinson Disease
|
Concept
|
Gastrointestinal Diseases
|
Concept
|
Heart Diseases
|
Concept
|
Huntington Disease
|
Academic Article
|
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease.
|
Academic Article
|
Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.
|
Academic Article
|
Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease.
|
Academic Article
|
Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases.
|
Academic Article
|
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-?.
|
Academic Article
|
Suppression of nuclear factor-?B activation and inflammation in microglia by physically modified saline.
|
Academic Article
|
Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense.
|
Academic Article
|
Abnormality in catalase import into peroxisomes leads to severe neurological disorder.
|
Academic Article
|
Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.
|
Academic Article
|
Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
|
Academic Article
|
Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.
|
Academic Article
|
Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor a: implications for late infantile Batten disease therapy.
|
Academic Article
|
Enhancement of morphological plasticity in hippocampal neurons by a physically modified saline via phosphatidylinositol-3 kinase.
|
Academic Article
|
Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide.
|
Academic Article
|
Lipid-lowering drugs.
|
Academic Article
|
Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): implications for Alzheimer disease therapy.
|
Academic Article
|
Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders.
|
Academic Article
|
Ankyrin repeat and BTB/POZ domain containing protein-2 inhibits the aggregation of alpha-synuclein: implications for Parkinson's disease.
|
Academic Article
|
Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps.
|
Academic Article
|
Protection of dopaminergic neurons in a mouse model of Parkinson's disease by a physically-modified saline containing charge-stabilized nanobubbles.
|
Academic Article
|
Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons.
|
Academic Article
|
Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21rac and Protect Memory and Learning in an Animal Model of Alzheimer's Disease.
|
Academic Article
|
Activation of peroxisome proliferator-activated receptor a stimulates ADAM10-mediated proteolysis of APP.
|
Academic Article
|
A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.
|
Academic Article
|
Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
|
Academic Article
|
Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease.
|
Academic Article
|
HMG-CoA Reductase Inhibitors Bind to PPARa to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice.
|
Academic Article
|
Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders.
|
Academic Article
|
Can cinnamon bring aroma in Parkinson's disease treatment?
|
Academic Article
|
Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis.
|
Academic Article
|
Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints.
|
Academic Article
|
Attenuation of microglial RANTES by NEMO-binding domain peptide inhibits the infiltration of CD8(+) T cells in the nigra of hemiparkinsonian monkey.
|
Academic Article
|
Protection of Tregs, suppression of Th1 and Th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.
|
Academic Article
|
Up-regulation of microglial CD11b expression by nitric oxide.
|
Academic Article
|
Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease.
|
Academic Article
|
Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases.
|
Academic Article
|
Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.
|
Academic Article
|
Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
|
Academic Article
|
Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease.
|
Academic Article
|
Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase.
|
Academic Article
|
A simplified method for isolating highly purified neurons, oligodendrocytes, astrocytes, and microglia from the same human fetal brain tissue.
|
Academic Article
|
BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson's Disease.
|
Academic Article
|
Prospects of statins in Parkinson disease.
|
Academic Article
|
Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
|
Academic Article
|
Signals for the induction of nitric oxide synthase in astrocytes.
|
Academic Article
|
Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis.
|
Academic Article
|
HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.
|
Academic Article
|
Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson's Disease.
|
Academic Article
|
Correction: A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease.
|
Academic Article
|
Upregulation of Myelin Gene Expression by a Physically-Modified Saline via Phosphatidylinositol 3-Kinase-Mediated Activation of CREB: Implications for Multiple Sclerosis.
|
Academic Article
|
Store depletion-induced h-channel plasticity rescues a channelopathy linked to Alzheimer's disease.
|
Academic Article
|
Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARa.
|
Academic Article
|
Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology.
|
Academic Article
|
Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.
|
Academic Article
|
Cinnamic acid activates PPARa to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer's disease mouse model.
|
Academic Article
|
Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
|
Academic Article
|
Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson's Disease via Peroxisome Proliferator-Activated Receptora.
|
Academic Article
|
Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARa: Implications for late-infantile Batten disease therapy.
|
Academic Article
|
Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF.
|
Academic Article
|
Aspirin up-regulates suppressor of cytokine signaling 3 in glial cells via PPARa.
|
Academic Article
|
Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer's Disease via Peroxisome Proliferator-Activated Receptor a.
|
Academic Article
|
RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.
|
Academic Article
|
A Broad Application of CRISPR Cas9 in Infectious, Inflammatory and Neurodegenerative Diseases.
|
Academic Article
|
PPARa serves as a new receptor of aspirin for neuroprotection.
|
Academic Article
|
RNS60, a physically-modified saline, inhibits glial activation, suppresses neuronal apoptosis and protects memory in a mouse model of traumatic brain injury.
|
Academic Article
|
Upregulation of BDNF and hippocampal functions by a hippocampal ligand of PPARa.
|
Academic Article
|
IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12R?1 internalization and suppress EAE.
|
Academic Article
|
Reduction of Lewy Body Pathology by Oral Cinnamon.
|
Academic Article
|
Can cinnamon spice down autoimmune diseases?
|
Academic Article
|
Is COVID-19 Gender-sensitive?
|
Academic Article
|
ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy.
|
Academic Article
|
Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARa-Dependent Astrocytic GDNF Pathway.
|
Academic Article
|
Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate.
|
Academic Article
|
Selective targeting of the TLR2/MyD88/NF-?B pathway reduces a-synuclein spreading in vitro and in vivo.
|
Academic Article
|
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Improves Cognitive Functions in Mice after Controlled Cortical Impact Injury.
|
Academic Article
|
Upregulation of DJ-1 in Dopaminergic Neurons by a Physically-Modified Saline: Implications for Parkinson's Disease.
|
Academic Article
|
Muscle-building supplement ?-hydroxy ?-methylbutyrate binds to PPARa to improve hippocampal functions in mice.
|
Academic Article
|
Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer's disease-related mouse models.
|
Academic Article
|
Treadmill exercise reduces a-synuclein spreading via PPARa.
|
Academic Article
|
Treadmill workout activates PPARa in the hippocampus to upregulate ADAM10, decrease plaques and improve cognitive functions in 5XFAD mouse model of Alzheimer's disease.
|
Academic Article
|
Activation of PPARa Exhibits Therapeutic Efficacy in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis.
|
Academic Article
|
Protection of Mice from Controlled Cortical Impact Injury by Food Additive Glyceryl Tribenzoate.
|
Academic Article
|
Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor a.
|